Scientists have discovered that some cancer cells pretend to be ‘super fit’ to fool normal healthy cells into giving them ...

Michael Parry was diagnosed with pancreatic cancer at the age of 59. Fortunately, his disease was detected early – and after surgery and chemotherapy, he is now planning for the years ahead with his ...

Our competitive PhD programme is designed for the next generation of world-leading scientists who want a career in cancer research. Our PhD students benefit from an above average salary and ...

Professor Clare Isacke aims to identify the processes by which tumour cells recruit non-cancerous cells during metastasis. She has held several senior positions at the ICR, including acting as Interim ...

The National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research is the only BRC focused ...

An opportunity to broaden your understanding of the capabilities and potential of MRI guidance in radiotherapy planning and treatment verification. We invite you to join us to hear from leading ...

Professor Banerji's group focuses on the development and validation of quantifiable and reproducible robust pharmacodynamic biomarkers in normal and tumour tissue that can be used in first-in-human ...

Professor Jessica Downs is Deputy Head of the Division of Cancer Biology. She is investigating the interplay between epigenetics and genome stability. The goal of this research is to understand how ...

Professor Richard Houlston is Head of the Division of Genetics and Epidemiology. His research focuses on the identification and characterisation of genetic susceptibility to cancer. Group: Myeloma ...

Professor Axel Behrens' group uses a combination of sophisticated genetics and human cancer organoids to understand the biology of cancer and to develop novel therapeutic options, with an emphasis on ...

Scientists have identified a new class of targeted cancer drugs that offer the potential to treat patients whose tumours have faulty copies of the BRCA cancer genes. The drugs, known as POLQ ...

Biomarkers – biological tests that give key information about a patient – have a huge role to play in the future of precision medicine which is why ten leading institutions, charities, stakeholder ...